Stockscreener 앱 받기
8.0439
0.50%
0.0539
전일 마감가:
$7.99
열려 있는:
$7.94
하루 거래량:
803.06K
Relative Volume:
0.34
시가총액:
$1.30B
수익:
$181.41M
순이익/손실:
$-59.56M
주가수익비율:
-19.15
EPS:
-0.42
순현금흐름:
$-38.83M
1주 성능:
-1.23%
1개월 성능:
+7.21%
6개월 성능:
+93.03%
1년 성능:
+175.95%
1일 변동 폭
$7.775
$8.0799
1주일 범위
$7.775
$8.46
52주 변동 폭
$2.82
$8.505
Xeris Biopharma Holdings Inc Stock (XERS) Company Profile
명칭
Xeris Biopharma Holdings Inc
전화
844-445-5704
주소
1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL
XERS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XERS
Xeris Biopharma Holdings Inc
|
8.04 | 1.29B | 181.41M | -59.56M | -38.83M | -0.42 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.20 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
471.85 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
553.46 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
807.98 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
330.21 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Xeris Biopharma Holdings Inc Stock (XERS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-12 | 재개 | H.C. Wainwright | Buy |
| 2024-11-11 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-03-28 | 개시 | Oppenheimer | Outperform |
| 2023-08-28 | 개시 | Craig Hallum | Buy |
| 2022-10-21 | 개시 | Jefferies | Buy |
| 2022-04-28 | 개시 | Craig Hallum | Buy |
| 2021-11-17 | 개시 | SVB Leerink | Outperform |
| 2021-10-29 | 개시 | H.C. Wainwright | Buy |
| 2021-04-07 | 재개 | RBC Capital Mkts | Outperform |
| 2020-02-18 | 개시 | Piper Sandler | Overweight |
| 2018-07-16 | 개시 | Jefferies | Buy |
| 2018-07-16 | 개시 | Leerink Partners | Outperform |
| 2018-07-16 | 개시 | RBC Capital Mkts | Outperform |
모두보기
Xeris Biopharma Holdings Inc 주식(XERS)의 최신 뉴스
When is the best time to exit Xeris Biopharma Holdings Inc.Analyst Downgrade & Accurate Buy Signal Alerts - newser.com
Xeris Biopharma Holdings Inc. stock prediction for this weekEarnings Trend Report & Verified Short-Term Trading Plans - newser.com
Beat the Market the Zacks Way: MariMed, Xeris Biopharma, Lam Research in Focus - Yahoo Finance
How to read the order book for Xeris Biopharma Holdings Inc.Bear Alert & Safe Entry Point Identification - newser.com
Risk vs reward if holding onto Xeris Biopharma Holdings Inc.2025 Top Decliners & Reliable Entry Point Alerts - newser.com
Why Xeris Biopharma Holdings Inc. (2B30) stock could be top winnerQuarterly Trade Report & Low Volatility Stock Recommendations - newser.com
Can Xeris Biopharma Holdings Inc. recover in the next quarter2025 Valuation Update & Reliable Momentum Entry Alerts - newser.com
Volume spikes in Xeris Biopharma Holdings Inc. stock – what they meanJuly 2025 Macro Moves & Capital Efficiency Focused Ideas - newser.com
What is the fair value estimate for Xeris Biopharma Holdings Inc. (2B30) stock in 2025Weekly Market Summary & Free Safe Entry Trade Signal Reports - newser.com
Analyzing net buyer seller activity in Xeris Biopharma Holdings Inc.IPO Watch & Reliable Intraday Trade Plans - newser.com
Is it time to cut losses on Xeris Biopharma Holdings Inc.2025 Key Highlights & Community Verified Trade Alerts - newser.com
Measuring Xeris Biopharma Holdings Inc.’s beta against major indicesTrade Risk Summary & Free Growth Oriented Trading Recommendations - newser.com
How buyback programs support Xeris Biopharma Holdings Inc. (2B30) stock2025 AllTime Highs & Low Risk Growth Stock Ideas - newser.com
Weiss Ratings Reiterates Sell (D-) Rating for Xeris Biopharma (NASDAQ:XERS) - MarketBeat
Xeris Biopharma (NASDAQ:XERS) Stock Price Down 4%Here's What Happened - MarketBeat
Xeris Biopharma Holdings (XERS): Exploring Valuation as Analysts Grow Bullish on Breakeven Prospects and Earnings Progress - simplywall.st
Xeris Biopharma Reaches New 52-Week High of $8.51, Up 253% - Markets Mojo
News impact scoring models applied to Xeris Biopharma Holdings Inc.Portfolio Value Summary & Growth Focused Stock Pick Reports - newser.com
Xeris Biopharma Holdings Inc.’s volatility index tracking explainedMarket Risk Analysis & Low Risk Investment Opportunities - newser.com
Will Xeris Biopharma Holdings Inc. outperform the marketJuly 2025 Big Picture & AI Enhanced Trading Alerts - newser.com
Will Xeris Biopharma Holdings Inc. stock deliver shareholder valueJuly 2025 Market Mood & Low Drawdown Momentum Ideas - newser.com
Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635c4 - MarketScreener
XERS Back In The Spotlight As Recorlev Surges, Gvoke Steadies, And Keveyis Holds Strong - RTTNews
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Xeris Biopharma's Path Toward Profitability Might Change The Case For Investing In XERS - simplywall.st
Xeris Biopharma (XERS) is a Great Momentum Stock: Should You Buy? - sharewise.com
Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS): Are Analysts Optimistic? - Yahoo Finance
Xeris Biopharma Holdings, Inc. (XERS) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
Why Xeris Biopharma Holdings Inc. stock could be next big winnerQuarterly Earnings Summary & Detailed Earnings Play Strategies - newser.com
Why Xeris Biopharma Holdings Inc. (2B30) stock could outperform next yearMarket Movement Recap & AI Enhanced Trading Signals - newser.com
Can Xeris Biopharma Holdings Inc. stock weather global recession2025 Support & Resistance & Daily Profit Focused Stock Screening - newser.com
Published on: 2025-10-03 05:03:07 - newser.com
Leading vs lagging indicators on Xeris Biopharma Holdings Inc. performanceWeekly Profit Summary & Risk Managed Investment Strategies - newser.com
Is Xeris Biopharma Holdings Inc. (2B30) stock supported by strong fundamentalsJobs Report & Free Accurate Trade Setup Notifications - newser.com
Xeris Biopharma (NASDAQ:XERS) Hits New 12-Month HighTime to Buy? - MarketBeat
Xeris Biopharma Holdings Inc (XERS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.09%
자본화:
|
볼륨(24시간):